Success Story: Without RFE Issue, We Helped A Postdoctoral Research Associate in the Field of Biochemistry and Molecular Biology Secure an NIW Petition Approved

 

Client’s Testimonial:

“Thank you for the message, and thanks so much for all your help during my case preparation.”


On April 29th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Research Associate in the Field of Biochemistry and Molecular Biology (Approval Notice).


General Field: Biochemistry and Molecular Biology

Position at the Time of Case Filing: Postdoctoral Research Associate

Country of Origin: Sri Lanka

State of Residence at the Time of Filing: Missouri

Approval Notice Date: April 29th, 2025

Processing Time: 16 months, 8 days


Case Summary:

We are pleased to share the NIW approval without receiving any RFE issues of a postdoctoral research associate from Sri Lanka, whose innovative research in biochemistry and molecular biology is helping shape the future of targeted cancer therapy. Her proposed endeavor focuses on understanding how DNA replication stress responses are triggered by chemotherapeutic agents, work that enables the identification of new drug targets for precision treatment.

At the time of filing, the client was working as a postdoctoral researcher at a U.S.-based medical institution, where she continues to contribute to advancements in cancer biology. Her research has already improved our understanding of how cellular signaling pathways impact cancer development and treatment resistance.

Key achievements highlighted in the petition include:

  • 13 peer-reviewed publications, with 4 first-authored papers, published in well-regarded journals in her field;
  • 219 citations, with 6 papers ranked among the top 10–20% most cited in molecular biology and genetics for their publication years;
  • At least 2 peer reviews completed, reflecting her recognition as an expert by fellow researchers.
The petition demonstrated the national importance of her research, especially given cancer’s high mortality and economic burden in the U.S. Her studies on G protein signaling, statin-induced modulation of cellular pathways, and GPCR mechanisms have been widely cited by researchers across disciplines and countries. Funding support from the National Institutes of Health further underscores the value of her work to U.S. biomedical goals.

We congratulate our client on this important milestone and look forward to her continued contributions to cancer research and treatment strategies that improve health outcomes for patients across the country.